Drug intelligence / Profile preview

Microcyn Endocyn

Development stage
Unknown
Lead developer
Sonoma Pharmaceuticals
Modality
Small Molecules
Administration
Topical, Dental/endo Irrigation
01

Overview

Microcyn Endocyn is a pH-neutral, hypochlorous acid (HOCl)-based wound and dental irrigant that leverages the Microcyn technology platform, known for its broad-spectrum antimicrobial properties and rapid disruption of bacterial biofilms. The active ingredients are primarily hypochlorous acid and sodium hypochlorite in a stabilized aqueous solution. HOCl, the chief antimicrobial agent, mimics the natural product of human immune cells (neutrophils) used to destroy pathogens via oxidative mechanisms. Microcyn Endocyn rapidly kills bacteria, viruses, fungi, and spores, and simultaneously exerts anti-inflammatory and regenerative effects by reducing inflammation and promoting tissue repair. The primary indications are wound cleansing, debridement, and irrigation, with dental applications as an irrigant in endodontic procedures[5][10].

Brand names
Microcyn Endocyn
Other names
EndoGenix Endocyn Irrigant
02

Targets

Chitin

Beyond the preview

Go deeper on Microcyn Endocyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microcyn Endocyn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call